EVH Evolent Health, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Evolent Health, Inc. (EVH) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 25, 2026, a 10-Q quarterly report filed on May 7, 2026, an 8-K current report filed on August 6, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Evolent Health, Inc. (EVH) (SEC CIK 1628908), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Evolent Health, Inc.
Ask AI about EVH filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting EVH positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on EVH.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Evolent Health, Inc. (EVH) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Aug 6, 2026 | - | - | - |
8-K | Jun 4, 2026 | - | - | |
10-Q | May 7, 2026 | Mar 31, 2026 | - | |
8-K | May 7, 2026 | - | - | |
10-K | Feb 25, 2026 | Dec 31, 2025 | - | |
8-K | Feb 24, 2026 | - | Analysis | - |
8-K | Dec 8, 2025 | - | - | |
8-K | Dec 2, 2025 | - | - | |
10-Q | Nov 7, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 11, 2025 | Jun 30, 2025 | - | |
10-Q | May 9, 2025 | Mar 31, 2025 | - | |
10-K | Feb 21, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 8, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 9, 2024 | Jun 30, 2024 | - | |
SC 13G | Jun 17, 2024 | - | - | |
10-Q | May 10, 2024 | Mar 31, 2024 | - | |
10-K | Feb 23, 2024 | Dec 31, 2023 | - | |
SC 13G | Feb 8, 2024 | - | - | |
10-Q | Nov 2, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 3, 2023 | Jun 30, 2023 | - | |
10-Q | May 4, 2023 | Mar 31, 2023 | - | |
SC 13G | Apr 10, 2023 | - | - | |
10-K | Feb 24, 2023 | Dec 31, 2022 | - | |
SC 13G | Jan 27, 2023 | - | - | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate EVH share value held by 13F filers tracked by SignalX, by quarter.
- BlackRock+557.3K (+5%)
- Goldman Sachs Group+403.1K (+22%)
- Citigroup+227.6K (+39%)
- D.E. Shaw & Co+164.7K (+3%)
- FMR LLC (Fidelity)+11.8K (+84%)
- Citadel Advisors LLC1.16M (-59%)
- Millennium Management1.10M (-75%)
- Two Sigma Investments666.0K (-43%)
- Dimensional Fund Advisors517.5K (-22%)
- State Street Corp295.4K (-10%)
- Prudential Financial+18.8K
- Fifth Third Bancorp+1.2K
- Vanguard Group Inc−8.91M
- JPMorgan Chase & Co−2.95M
- Ameriprise Financial−532.1K
- Invesco Ltd−392.3K
- Renaissance Technologies LLC−174.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 177 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest EVH SEC filings in 2026?
Evolent Health, Inc. (EVH) has filed a 10-K annual report on February 25, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on August 6, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did EVH file its most recent 10-K annual report?
Evolent Health, Inc. (EVH) filed its most recent 10-K annual report on February 25, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view EVH 10-Q quarterly reports?
Evolent Health, Inc. (EVH)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every EVH 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has EVH filed recently?
Evolent Health, Inc. (EVH)'s most recent 8-K was filed on August 6, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find EVH insider trading activity (Form 4)?
SignalX aggregates every EVH Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does EVH file with the SEC?
Evolent Health, Inc. (EVH) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new EVH filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Evolent Health, Inc. (EVH).
What is EVH's SEC CIK number?
Evolent Health, Inc. (EVH)'s SEC CIK (Central Index Key) number is 1628908. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1628908 to look up all EVH filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Evolent Health, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 69+ filings.